(Q52302722)

29 April 2018

title

Addiction potential of phentermine prescribed during long-term treatment of obesity. (English)

1 reference

29 April 2018

0 references

2

1 reference

29 April 2018

author name string

E J Hendricks

1

1 reference

29 April 2018

S L Schmidt

3

1 reference

29 April 2018

M Haggard

4

1 reference

29 April 2018

S Souter

5

1 reference

29 April 2018

C L Mitchell

6

1 reference

29 April 2018

D G De Marco

7

1 reference

29 April 2018

M J Hendricks

8

1 reference

29 April 2018

Y Istratiy

9

1 reference

29 April 2018

F L Greenway

10

1 reference

29 April 2018

language of work or name

English

0 references

publication date

17 May 2013

1 reference

29 April 2018

International Journal of Obesity

published in

1 reference

29 April 2018

volume

38

1 reference

29 April 2018

issue

2

1 reference

29 April 2018

page(s)

292-298

1 reference

29 April 2018

https://scigraph.springernature.com/pub.10.1038/ijo.2013.74

exact match

0 references

cites work

Management of obesity in the National Health and Nutrition Examination Survey (NHANES), 2007-2008.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.74

Anorectics on trial: a half century of federal regulation of prescription appetite suppressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.74

Long-term pharmacotherapy of obesity 2000: a review of efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.74

Pharmacotherapies for obesity: past, current, and future therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.74

Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse-controlled release for obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.74

Effects on weight reduction and safety of short-term phentermine administration in Korean obese people

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.74

The long-term management of obesity with continuing pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.74

Blood pressure and heart rate effects, weight loss and maintenance during long-term phentermine pharmacotherapy for obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.74

Treatment of obesity with "combination" pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.74

How physician obesity specialists use drugs to treat obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.74

A study of abrupt phentermine cessation in patients in a weight management program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.74

The development of a cocaine craving questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.74

Amphetamine withdrawal: I. Reliability, validity and factor structure of a measure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.74

Heroin and cocaine craving and use during treatment: measurement validation and potential relationships.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.74

Can the severity of dependence scale be usefully applied to 'ecstasy'?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.74

Determining a diagnostic cut-off on the Severity of Dependence Scale (SDS) for cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.74

The Severity of Dependence Scale (SDS) in an adolescent population of cannabis users: reliability, validity and diagnostic cut-off.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.74

The clinical significance of drug craving

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.74

Theories of addiction: methamphetamine users' explanations for continuing drug use and relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.74

The nature, time course and severity of methamphetamine withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.74

Comparisons of methamphetamine psychotic and schizophrenic symptoms: a differential item functioning analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.74

Pharmacologic mechanisms of crystal meth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.74

Withdrawal symptoms in abstinent methamphetamine-dependent subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.74

Abuse liability assessment of atomoxetine in a drug-abusing population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.74

Human abuse potential and cognitive effects of taranabant, a cannabinoid 1 receptor inverse agonist: a randomized, double-blind, placebo- and active-controlled, crossover study in recreational polydrug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.74

Frequency of Use or Abuse of Amphetamine-Related Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.74

Addiction liability of pharmacotherapeutic interventions in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.74

What’s in a Word? Addiction Versus Dependence in DSM-V

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.74

Reliability and validity of the Cocaine Selective Severity Assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.74

Outcome predictors in cocaine dependence treatment trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.74

Predictors of treatment outcome in outpatient cocaine and alcohol dependence treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.74

Detection of phentermine in hair samples from drug suspects

21 January 2018

1 reference

12 December 2020

Treatment for amphetamine withdrawal

1 reference

12 December 2020

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10

1 reference

12 December 2020

What's in a word? Addiction versus dependence in DSM-V.

1 reference

12 December 2020

Locomotor activity and anorexogenic action

1 reference

12 December 2020

Prevalence of drug use in commercial tractor-trailer drivers

1 reference

12 December 2020

Choosing a cut-off on the Severity of Dependence Scale (SDS) for amphetamine users.

1 reference

12 December 2020

Evaluation of Phentermine and Fenfluramine, Alone and in Combination, in Normal, Healthy Volunteers

1 reference

12 December 2020

The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users.

1 reference

12 December 2020

Cochrane Database of Systematic Reviews

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.74

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/IJO.2013.74

1 reference

29 April 2018

PubMed ID

23736363

1 reference

29 April 2018